Your session is about to expire
← Back to Search
Behavioral Intervention
Digital Resilience Program for Advance Care Planning
N/A
Recruiting
Led By Li-Ting H. Longcoy
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Family caregivers must be age ≥ 18 years
Patients must be age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately at the end of the think-aloud interview
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to create a special online program to help East Asian immigrants talk to their family about planning for their future care.
Who is the study for?
This trial is for East Asian immigrants over 18 with a cancer diagnosis, who can communicate in English or certain East Asian languages. They must have a family caregiver to join the study and be comfortable using digital tools as shown by their health literacy score.
What is being tested?
The study is testing a digital program designed specifically for East Asian immigrants to help them talk about future healthcare plans with their caregivers. It aims to build resilience and make these discussions easier.
What are the potential side effects?
Since this intervention involves culturally sensitive communication training rather than medical treatment, there are no direct physical side effects expected from participating in this trial.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My caregiver is 18 years old or older.
Select...
I am 18 years old or older.
Select...
My cancer diagnosis is officially recorded in my medical records.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately at the end of the think-aloud interview
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately at the end of the think-aloud interview
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Usability
Secondary study objectives
Acceptability
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Culturally Tailored Digital Resilience-BuildingExperimental Treatment1 Intervention
The Culturally Tailored Resilience-Building intervention will be provided to East Asian immigrants with cancer and their family caregivers.
Find a Location
Who is running the clinical trial?
Rockefeller UniversityOTHER
160 Previous Clinical Trials
16,472 Total Patients Enrolled
University of Illinois at ChicagoLead Sponsor
640 Previous Clinical Trials
1,568,744 Total Patients Enrolled
2 Trials studying Advance Care Planning
54 Patients Enrolled for Advance Care Planning
Li-Ting H. LongcoyPrincipal InvestigatorUniversity of Illinois Chicago College of Nursing